Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-25-035182

Options or other derivatives

  • CEO and President acquired 1,580,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KLEMP WALTER V CEO and President 2025-11-12 Grant or award · Stock option (right to buy) +830,000 3,210,731 D
KLEMP WALTER V CEO and President 2025-11-12 Grant or award · Performance Based Restricted Stock Units +750,000 3,960,731 D
Loading xslF345X05/rdgdoc.xml…